PAG
LEGN icon

Private Advisor Group’s Legend Biotech LEGN Stock Holding History

Private Advisor Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,756
Closed -$321K – 2791
2025
Q4 		$321K Sell
14,756
-6,860
-32% -$197K ﹤0.01% 2111
2025
Q3 		$705K Sell
21,616
-130
-0.6% -$4.8K ﹤0.01% 1579
2025
Q2 		$772K Buy
+21,746
New +$705K ﹤0.01% 1433

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Private Advisor Group's LEGN Position: Q1 2026 in Review

Private Advisor Group sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 14,756 shares — an estimated $321K sold.

Private Advisor Group first reported a position in LEGN in Q2 2025 and held it in 3 quarters. The position peaked at $772K in Q2 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Private Advisor Group reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Private Advisor Group sold 14,756 Legend Biotech shares in Q1 2026, an estimated $321K.
  • Private Advisor Group first reported a position in Legend Biotech in Q2 2025 and held it in 3 quarters.
  • Private Advisor Group's Legend Biotech position peaked at $772K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.